2m 2m 2m 2m 2m 2m 2m
Fulgent Genetics (FLGT)
NASDAQ
$20.00-$0.13 (-0.67%)
Price as of Oct 22, 2026 7:30 PM EDT- $553.9MMarket Cap
- -14.34%1-Year Change
- Diagnostics & ResearchIndustry
Fulgent Genetics (FLGT)
$20.00-$0.13 (-0.67%)
FLGT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $20.13 | ||
Change | -$0.20 (-0.98%) | ||
Open | $20.21 | ||
High | $20.50 | ||
Low | $19.98 | ||
Previous Close | $20.33 | ||
Volume | 193,390 | ||
30-Day Average Volume | 277,814 | ||
1-Week Change | -4.19% | ||
1-Month Change | -6.55% | ||
1-Year Change | -14.34% | ||
3-Year Change | -20.78% | ||
5-Year Change | -76.27% | ||
Fundamentals | |||
Shares Outstanding | 27.5M | ||
Total Assets | $1.1B | ||
Market Cap | $553.9M | ||
Enterprise Value | $531.5M | ||
Period: QTR TTM FY | |||
Revenue | $85.4M | ||
Net Income | -$29.5M | ||
Free Cash Flow | -$27.6M | ||
EBIT | -$29.5M | ||
EBITDA | -$21.8M | ||
Net Working Capital | $383.0M | ||
EPS | N/A | ||
Enterprise Value/EBITDA | -24 | ||
Enterprise Value/Revenue | 6 | ||
P/B | 1 | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | -20 | ||
Price/Operating Cash Flow | -23 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue